Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105
05 juin 2023 08h00 HE
|
Rani Therapeutics, LLC
SAN JOSE, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Rani Therapeutics Appoints Kate McKinley as Chief Business Officer
24 mai 2023 08h00 HE
|
Rani Therapeutics, LLC
SAN JOSE, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Immuneering Appoints Harold E. Brakewood as Chief Business Officer
28 mars 2023 08h00 HE
|
Immuneering Corporation
CAMBRIDGE, Mass., March 28, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company developing medicines for broad populations of cancer patients with an...
Buffini & Company Announces 2023 Event Lineup
26 oct. 2022 12h25 HE
|
Buffini & Company
Carlsbad, Oct. 26, 2022 (GLOBE NEWSWIRE) -- (Oct. 26, 2022) The just announced 2023 lineup of Buffini & Company events has been created to motivate, inspire and change the lives and businesses...
EGIDE : renforce son offre et sa stratégie commerciale avec la création d'une équipe de Business Development et la nomination de deux experts
17 mai 2021 01h00 HE
|
EGIDE
Bollène, le 17 mai 2021 – 07 :00 (CET)Communiqué de presse Le Groupe Egide renforce son offre et sa stratégie commercialeavec la création d'une équipe de Business Developmentet la nomination de...
Egide: strengthens its offer and business strategy with the creation of a business development team and the appointment of two experts
17 mai 2021 01h00 HE
|
EGIDE
Bollène, May 17, 2021 – 07:00am (CET)Press Release The Egide Group strengthens its offer and business strategywith the creation of a business development team and the appointment of two experts ...